Up Close with Tarlatamab
Last Updated: July 24, 2026
Discover more about tarlatamab-dlle (IMDELLTRA™).
Related Resources:
Perspectives
OncolyticsToday: The Bispecific Antibody Revolution
Author: KELLY BRUNK
Last Updated: 04/01/2024
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 09/09/2026
Up Close with Linvoseltamab
Last Updated: 06/29/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
PQI Podcast
PQI
Patient Education Sheet
PQI
S11 E9: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms
Last Updated: 10/17/2026
PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer
Last Updated: 10/15/2026
Tocilizumab (Actemra)
Last Updated: 10/12/2026
PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer
Last Updated: 09/09/2026